KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 561.53M
Enterprise Value 340.14M
Trailing P/E N/A
Forward P/E 1-13.25
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)6.55
Price/Book (mrq)1.00
Enterprise Value/Revenue 34.27
Enterprise Value/EBITDA 6-1.07

Trading Information

Stock Price History

Beta (5Y Monthly) 2.06
52-Week Change 3-74.15%
S&P500 52-Week Change 35.66%
52 Week High 32.3800
52 Week Low 30.3000
50-Day Moving Average 30.6440
200-Day Moving Average 30.7002

Share Statistics

Avg Vol (3 month) 3315.92k
Avg Vol (10 day) 3190.19k
Shares Outstanding 5116.1M
Float 94.36M
% Held by Insiders 117.63%
% Held by Institutions 12.28%
Shares Short (Jun. 29, 2020) 41.19M
Short Ratio (Jun. 29, 2020) 42.61
Short % of Float (Jun. 29, 2020) 4N/A
Short % of Shares Outstanding (Jun. 29, 2020) 40.53%
Shares Short (prior month May 28, 2020) 41.26M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:8
Last Split Date 3May 23, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Mar. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-403.70%

Management Effectiveness

Return on Assets (ttm)-35.28%
Return on Equity (ttm)-68.80%

Income Statement

Revenue (ttm)9.39M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)-9.10%
Gross Profit (ttm)2.44M
EBITDA -37.36M
Net Income Avi to Common (ttm)-37.61M
Diluted EPS (ttm)-0.3360
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)24.32M
Total Cash Per Share (mrq)0.21
Total Debt (mrq)2.93M
Total Debt/Equity (mrq)4.77
Current Ratio (mrq)5.19
Book Value Per Share (mrq)0.53

Cash Flow Statement

Operating Cash Flow (ttm)-34.46M
Levered Free Cash Flow (ttm)-25.23M